Brief: PolarityTE Submits IND Application For SkinTE In Chronic Cutaneous Ulcers
26/07/2021 13:43
July 26 (Reuters) - PolarityTE Inc PTE.O :
* POLARITYTE SUBMITS INVESTIGATIONAL NEW DRUG APPLICATION
FOR
SKINTE® IN CHRONIC CUTANEOUS ULCERS
Source text for Eikon: ID:nBw8zMPZQa
Further company coverage: PTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RegenETP,
See all newsBrief: PolarityTE Receives Delisting Notice From Nasdaq
U.S. STOCKS ON THE MOVE-Biogen, Phoenix Motor, Mastercard
U.S. STOCKS ON THE MOVE-Energy sector, Affirm, Stitch Fix
U.S. STOCKS ON THE MOVE-Shutterstock, Salesforce, Plug Power
Brief: Polarityte And Its Subsidiaries Files Voluntary Petitions For Relief Under Chapter 11